RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

Reading between the lines--if the FDA was on the verge, this would read differently. They have not yet reviewed 'all the documents', which puts the time of decision-making and signing off by the necessary parties farther off as well. Personally, I'm am revising my expectations to 2nd week of July. I don't see anything in this that bodes negatively for the decision--just the timing.

And we would not have been better off if this was a formal clinical hold.

NeuroInvestment